Name: Latest research reports of Akums Drugs & Pharmaceuticals Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Akums Drugs & Pharmaceuticals Ltd.
Rating: 5
Author: KRChoksey

Akums Drugs & Pharmaceuticals Ltd.

NSE: AKUMS | BSE: 544222 | ISIN: INE09XN01023 | Industry: Pharmaceuticals
|

486.3500 -12.80 (-2.56%)

NSE Apr 17, 2025 15:31 PM

58.64% Fall from 52W High

Volume: 291.1K

Akums Drugs & Pharmaceuticals Ltd.

29 Jul 2024

486.35

-2.56%

IPO Note

IPO Subscribe: Akums Drugs & Pharmaceutic...

KRChoksey

Akums Drugs and Pharmaceuticals established in 2004 offers a comprehensive range of pharmaceutical products and services to cater to the diverse needs of its clients in India and abroad. Through its core CDMO business, it provides end-to-end solutions for product development and manufacturing.

Akums Drugs & Pharmaceuticals Ltd. is trading above its 30 day SMA of 481.6

The Baseline | 17 Apr 2025

Market closes higher, HDFC AMC's net profit beats Forecaster estimates by 8%

Trendlyne Marketwatch | 17 Apr 2025

Ashish Kacholia adds a consultancy player to his portfolio, Dolly Khanna cuts stake in 3 firms to below …

Ashish Kacholia | 17 Apr 2025